Adaptive Biotechnologies ADPT Operating Income
Operating Income at other companies
Other financials
Where this comes from
Reported directly by Adaptive Biotechnologies in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: Adaptive Biotechnologies’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Adaptive Biotechnologies's operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Adaptive Biotechnologies's operating income?
- Adaptive Biotechnologies (ADPT) reported operating income of -$19.21M in Q1 2026.
- How has Adaptive Biotechnologies's operating income changed year-over-year?
- Adaptive Biotechnologies's operating income increased by 35.1% year-over-year, from -$29.6M to -$19.21M.
- What is the long-term trend for Adaptive Biotechnologies's operating income?
- Over 4 years (2021 to 2025), Adaptive Biotechnologies's operating income has grown at a -27.7% compound annual growth rate (CAGR), from -$208.97M to -$57.12M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.